New weight-loss drugs appear safe and effective for people living with HIV
Another class of cancer drugs may contribute to curing HIV
Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate
“We went back to the community and told them it didn’t work” – lessons learned from a trial of youth-friendly health services
Top 5 stories on HIV in Asia from IAS 2023
Top 5 HIV PrEP stories from IAS 2023
Top 5 stories on co-infections and co-morbidities in people with HIV from IAS 2023
Top 5 HIV treatment stories from IAS 2023
Top 5 stories on HIV in Africa from IAS 2023
Thai key population-led organisations give hope for sustainable HIV financing
Undetectability as a ‘weird superpower’: experiences of people living with HIV in Australia
Injectable PrEP requires new testing procedures, IAS conference hears
Resistance history does not affect response to dolutegravir / lamivudine
Exposure to tenofovir-based PrEP in the womb does not affect children’s bone density
Are peer approaches the 'silver bullet' for increasing PrEP uptake in low-resource settings?
Breaking down the silos: integrating hepatitis C 'test and treat' services into ART clinics is possible
Mumbai shows triaging those with advanced HIV disease in government centres is feasible
Immediate ART associated with fewer deaths in Thailand, but starting a week or two later may lead to less virological failure
